[EN] ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF CANCER<br/>[FR] INHIBITEURS CHROMÉNONE ALLOSTÉRIQUES DE LA PHOSPHOINOSITIDE 3-KINASE (PI3K) POUR LE TRAITEMENT DU CANCER
申请人:PETRA PHARMA CORP
公开号:WO2022251482A1
公开(公告)日:2022-12-01
The disclosure relates to compounds of Formula (I) as allosteric chromenone inhibitors of phosphoinositide 3‑kinase (PI3K) useful in the treatment of diseases or disorders associated with PI3K modulation, Formula (I): (I) or pharmaceutically acceptable salts thereof wherein R, R1, R2,R3, R4, R5, R6, R7, and R8, are as defined herein. The disclosure also relates to methods of making and using compounds of Formula (I) or pharmaceutically acceptable salts thereof.
本公开涉及公式(I)的化合物,作为磷脂酰肌醇3-激酶(PI3K)的变构异构酮抑制剂,用于治疗与PI3K调节相关的疾病或疾病,其中公式(I):(I)或其药学上可接受的盐,其中R,R1,R2,R3,R4,R5,R6,R7和R8如本文所定义。本公开还涉及制备和使用公式(I)或其药学上可接受的盐的方法。